NES ZIONA, Israel--(BUSINESS WIRE)--June 19, 2006--Results of a study presented by Prof. Alain Berrebi at the 11th Congress of the European Hematology Association (EHA), June 15-18, 2006 in Amsterdam, indicate that NBM-100, a non-invasive hemoglobin/hematocrit monitoring system developed by OrSense Ltd., accurately measures levels of hemoglobin/hematocrit in both hospital and ambulatory settings.
